tiprankstipranks
Trending News
More News >
AstraZeneca plc (SE:AZN)
:AZN
Sweden Market
Advertisement

AstraZeneca (AZN) Ratios

Compare
1 Followers

AstraZeneca Ratios

SE:AZN's free cash flow for Q2 2025 was $0.75. For the 2025 fiscal year, SE:AZN's free cash flow was decreased by $ and operating cash flow was $0.25. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.86 0.82 0.86 1.16 0.96
Quick Ratio
0.67 0.64 0.68 0.76 0.76
Cash Ratio
0.21 0.19 0.23 0.28 0.39
Solvency Ratio
0.23 0.18 0.14 0.06 0.12
Operating Cash Flow Ratio
0.40 0.34 0.37 0.26 0.24
Short-Term Operating Cash Flow Coverage
2.06 2.02 1.56 2.24 2.15
Net Current Asset Value
$ -38.67B$ -36.90B$ -36.83B$ -39.83B$ -31.55B
Leverage Ratios
Debt-to-Assets Ratio
0.29 0.28 0.30 0.29 0.31
Debt-to-Equity Ratio
0.73 0.73 0.79 0.78 1.30
Debt-to-Capital Ratio
0.42 0.42 0.44 0.44 0.57
Long-Term Debt-to-Capital Ratio
0.36 0.36 0.39 0.43 0.56
Financial Leverage Ratio
2.51 2.58 2.61 2.68 4.27
Debt Service Coverage Ratio
2.08 1.93 1.30 1.39 2.07
Interest Coverage Ratio
7.15 5.16 2.79 0.81 3.95
Debt to Market Cap
0.13 0.13 0.14 0.19 0.17
Interest Debt Per Share
22.28 19.33 19.75 22.62 16.53
Net Debt to EBITDA
1.37 1.64 2.54 4.78 1.55
Profitability Margins
Gross Profit Margin
72.60%82.45%72.06%66.76%80.09%
EBIT Margin
20.83%18.61%8.64%2.70%19.49%
EBITDA Margin
32.87%30.37%20.48%13.66%30.37%
Operating Profit Margin
21.19%17.88%8.47%2.82%19.39%
Pretax Profit Margin
17.82%15.06%5.64%-0.71%14.71%
Net Profit Margin
14.74%13.00%7.41%0.30%12.01%
Continuous Operations Profit Margin
14.75%13.01%7.42%0.31%11.81%
Net Income Per EBT
82.70%86.32%131.47%-42.26%81.61%
EBT Per EBIT
84.10%84.21%66.57%-25.09%75.86%
Return on Assets (ROA)
7.51%5.89%3.41%0.11%4.79%
Return on Equity (ROE)
20.20%15.21%8.88%0.29%20.46%
Return on Capital Employed (ROCE)
15.40%11.61%5.35%1.28%11.12%
Return on Invested Capital (ROIC)
11.72%9.32%6.45%-0.53%8.49%
Return on Tangible Assets
15.85%13.85%8.80%0.26%9.42%
Earnings Yield
3.51%2.82%1.57%0.07%2.44%
Efficiency Ratios
Receivables Turnover
4.04 5.45 6.15 6.20 6.99
Payables Turnover
0.65 2.46 4.86 4.40 2.25
Inventory Turnover
2.43 1.48 2.64 1.38 1.32
Fixed Asset Turnover
4.33 4.36 4.69 3.68 2.98
Asset Turnover
0.51 0.45 0.46 0.36 0.40
Working Capital Turnover Ratio
-15.11 -9.97 -1.77K 25.92 -16.05
Cash Conversion Cycle
-316.97 164.91 122.66 239.59 167.50
Days of Sales Outstanding
90.24 66.98 59.35 58.83 52.19
Days of Inventory Outstanding
150.32 246.24 138.42 263.63 277.18
Days of Payables Outstanding
557.54 148.32 75.12 82.88 161.87
Operating Cycle
240.56 313.22 197.77 322.46 329.37
Cash Flow Ratios
Operating Cash Flow Per Share
8.64 6.62 6.34 4.21 3.66
Free Cash Flow Per Share
5.63 4.20 4.68 2.65 1.67
CapEx Per Share
3.01 2.42 1.66 1.55 1.99
Free Cash Flow to Operating Cash Flow
0.65 0.63 0.74 0.63 0.46
Dividend Paid and CapEx Coverage Ratio
1.39 1.25 1.41 0.98 0.78
Capital Expenditure Coverage Ratio
2.87 2.74 3.81 2.71 1.84
Operating Cash Flow Coverage Ratio
0.41 0.36 0.34 0.19 0.24
Operating Cash Flow to Sales Ratio
0.23 0.23 0.22 0.16 0.18
Free Cash Flow Yield
3.62%3.11%3.45%2.26%1.67%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
28.53 35.42 63.83 1.49K 41.06
Price-to-Sales (P/S) Ratio
4.21 4.60 4.73 4.45 4.93
Price-to-Book (P/B) Ratio
5.39 5.39 5.67 4.24 8.40
Price-to-Free Cash Flow (P/FCF) Ratio
27.63 32.12 29.00 44.25 59.84
Price-to-Operating Cash Flow Ratio
18.00 20.39 21.40 27.93 27.34
Price-to-Earnings Growth (PEG) Ratio
3.91 0.44 0.03 -15.37 0.30
Price-to-Fair Value
5.39 5.39 5.67 4.24 8.40
Enterprise Value Multiple
14.16 16.80 25.64 37.35 17.78
Enterprise Value
266.80B 233.69B 232.94B 190.97B 143.77B
EV to EBITDA
14.16 16.80 25.64 37.35 17.78
EV to Sales
4.66 5.10 5.25 5.10 5.40
EV to Free Cash Flow
30.58 35.59 32.19 50.75 65.56
EV to Operating Cash Flow
19.93 22.59 23.75 32.03 29.96
Tangible Book Value Per Share
-9.25 -12.14 -14.26 -16.29 -13.07
Shareholders’ Equity Per Share
28.85 25.04 23.93 27.69 11.91
Tax and Other Ratios
Effective Tax Rate
0.17 0.14 -0.32 1.43 0.20
Revenue Per Share
36.97 29.31 28.65 26.39 20.29
Net Income Per Share
5.45 3.81 2.12 0.08 2.44
Tax Burden
0.83 0.86 1.31 -0.42 0.82
Interest Burden
0.86 0.81 0.65 -0.26 0.75
Research & Development to Revenue
0.23 0.24 0.22 0.26 0.23
SG&A to Revenue
0.00 0.42 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.01 0.01 0.02 0.01
Income Quality
1.40 1.50 3.92 -22.50 1.23
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis